Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Erik S. Linklater, Elizabeth A. Tovar, Curt J. Essenburg, Lisa Turner, Zachary Madaj, Mary E. Winn, Marianne K. Melnik, Hasan Korkaya, Christiane R. Maroun, James G. Christensen, Matthew R. Steensma, Julie L. Boerner, Carrie R. Graveel
Published Sep 16, 2016 · Vol. 7, No. 43 · pp. 69903-69915
Emilie Desportes, Mathilde Wagner, Maud Kamal, Anne Vincent Salomon, Gabrielle Deniziaut, Gaëlle Pierron, Etienne Rouleau, Thomas Jouffroy, Christophe Le Tourneau, Xavier Paoletti, Vincent Servois
Published Sep 15, 2016 · Vol. 8, No. 1 · pp. 1760-1773
Gabriela Schneider, Ewa Bryndza, Agata Poniewierska-Baran, Karol Serwin, Malwina Suszynska, Zachariah P. Sellers, Michael L. Merchant, Alagammai Kaliappan, Janina Ratajczak, Magda Kucia, Nichola C. Garbett, Mariusz Z. Ratajczak
Published Sep 13, 2016 · Vol. 7, No. 43 · pp. 69829-69843